«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

28卷

期数:

2022年05期

页码:

503-507

栏目:

基础医学

出版日期:

2022-09-20

文章信息/Info

Title:

The protective effect and mechanism of captopril on myocardial injury in septic mice

文章编号:

1006-8147(2022)05-0503-05

作者:

孟祥龙刘艳存陈鑫森等

（天津医科大学总医院急诊医学科，天津 300052）

Author(s):

MENG Xiang-long; LIU Yan-cun; CHEN Xin-sen; GAO Yu-lei; CHAI Yan-fen

（Department of Emergency Medicine，General Hospital，Tianjin Medical University，Tianjin 300052，China）

关键词:

卡托普利; 脓毒症; 核转录因子-κB; 心肌损伤

Keywords:

captopril; sepsis; nuclear factor-κB; myocardial injury

分类号:

R631

DOI:

-

文献标志码:

A

摘要:

目的：研究卡托普利对脓毒症小鼠心肌损伤的保护作用并探讨其作用机制。方法：按随机数字表法将48只雄性C57BL/6J小鼠（6～8周龄）分为4组：对照组（Control组）、卡托普利组（Captopril组）、脂多糖组（LPS组）、卡托普利+脂多糖组（Captopril+LPS组），每组12只。实验前30 min，Captopril组和Captopril+LPS组预先经腹腔给予卡托普利（50 mg/kg）处理，Control组和LPS组给予等量生理盐水对照。采用腹腔注射脂多糖（LPS，15 mg/kg）的方法制备脓毒症模型（LPS组和Captopril+LPS组），Control组和Captopril组给予等量生理盐水。各组于制模后12 h采集标本，采用无创尾套测压法测量小鼠平均动脉压（MAP），酶联免疫吸附试验（ELISA）法检测血清炎性因子白细胞介素-6（IL-6）、肿瘤坏死因子-α（TNF-α）水平，HE染色观察心肌组织病理形态改变，高分辨小动物超声成像系统检测心功能，Western印迹检测心肌组织磷酸化核因子-κB p65（p-NF-κB p65）蛋白表达。结果：造模后12 h，Captopril组各项指标与Control组比较差异均无统计学意义（均P＞0.05）。与Control组相比，LPS组MAP下降（q=4.377，P＜0.05）；血清IL-6 、TNF-α水平明显升高（q=4.966、10.440，均P＜0.05）； 左室射血分数（LVEF%）、左室短轴缩短率（LVFS%）水平明显降低（q=6.104、6.390，均P＜0.01）；心肌纤维断裂，间质水肿，炎性细胞浸润加重；心肌组织p-NF-κB p65蛋白表达水平明显升高（q=12.430，P＜0.001）。和LPS组比较，Captopril+LPS组MAP差异无统计学意义（q=2.617，P＞0.05）；血清IL-6、TNF-α水平下降（q=4.085、5.721，均P＜0.05）； LVEF%、LVFS%水平升高（q=4.366、4.297，均P＜0.05）；心肌损伤病理改变减轻；心肌组织p-NF-κB p65蛋白表达水平下降（q=5.124，P＜0.01）。结论：卡托普利可能通过抑制核因子-κB的活化，减少炎性细胞因子（IL-6和TNF-α）产生，抑制脓毒症引起的心肌炎症，从而减轻脓毒症心肌损伤。

Abstract:

Objective： To investigate the protective effect of captopril on myocardial injury in septic mice and its mechanism. Methods： According to the random number table method，48 male C57BL/6J mice（6-8 weeks old） were divided into four groups：control group （Control group），captopril group（Captopril group），lipopolysaccharide group（LPS group），Captopril + lipopolysaccharide group（Captopril +LPS group），12 animals in each group. Captopril group and Captopril+LPS group were pre-treated with Captopril（50 mg/kg） via intraperitoneal administration 30 minutes before the experiment，and Control group and LPS group were given equal amount of saline control. The sepsis models（LPS and Captopril+LPS groups） were prepared by intraperitoneal injection of LPS（15 mg/kg），and the corresponding controls（Control and Captopril groups） were given equal amounts of saline. Specimens from each group were collected 12 h after modeling，and the mean arterial pressure（MAP） of mice was measured by non-invasive tail-sleeve manometry，serum levels of inflammatory factors interleukin-6 （IL-6） and tumor necrosis factor-α （TNF-α） were measured by enzyme-linked immunosorbent assay （ELISA），myocardial histomorphological changes were observed by HE staining，cardiac function was detected by high-resolution small animal ultrasound imaging system，and myocardial phospho-NF-κB p65（p-NF-κB p65） protein expression was detected by protein immunoblotting assay（Western blotting）. Results： At 12 h post-modelling，there was no statistically significant difference between the indexes of Captopril group and Control group （all P＞0.05）. Compared with the Control group，MAP decreased in the LPS group （q=4.377，P＜0.05）；serum IL-6，TNF-α levels were significantly higher（q=4.966，10.44，both P＜0.05）； left ventricular ejection fraction（LVEF%） and left ventricular short axis shortening（LVFS%） levels were significantly lower（q=6.104，6.39，both P＜0.01）；myocardial fibre breakage，interstitial oedema and increased inflammatory cell infiltration；myocardial tissue p-NF-κB p65 protein expression levels were significantly increased（q=12.43，P＜0.001）. There was no statistically significant difference in MAP between the Captopril+LPS and LPS groups（q=2.617，P＞0.05）. Serum IL-6 ，TNF-α levels decreased in the Captopril+LPS group（q=4.085，5.721，both P＜0.05）； LVEF%，LVFS% levels increased（q=4.366，4.297，both P＜0.05）；pathological changes of myocardial injury were alleviated，and the expression level of p-NF-κB p65 protein in myocardial tissue was decreased（q=5.124，P＜0.01）. Conclusion： Captopril may reduce sepsis myocardial injury by inhibiting the downstream activation of NF-κB and reducing the production of inflammatory cytokines（IL-6 and TNF-α） to suppress the sepsis-induced myocardial inflammatory response.

参考文献/References:

[1] EVANS L，RHODES A，ALHAZZANI W，et al. Surviving sepsis campaign：international guidelines for management of sepsis and septic shock 2021[J]. Intensive Care Med，2021，47（11）：1181-1247.
[2] 贺小丽，李德渊，乔莉娜，等. 脓毒症流行病学及预后的研究进展[J]. 中华危重病急救医学，2018，30（5）：486-489.
[3] XIE J，WANG H，KANG Y，et al. The epidemiology of sepsis in Chinese ICUs：a national cross-sectional survey[J]. Crit Care Med，2020，48（3）：e209-e218.
[4] LIU Y C，YU M M，SHOU S T，et al. Sepsis-induced cardiomyopathy：mechanisms and treatments[J]. Front Immunol，2017，8：1021.
[5] MONTICELLI J，DI BELLA S，DI MASI A，et al. Septic cardiomyopathy and bacterial exotoxins[J]. Crit Care Med，2018，46（9）：e965-e966.
[6] LI Y，ZENG Z，LI Y，et al. Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation[J]. Shock，2015，43（4）：395-404.
[7] CHEN H，LIU Q，LIU X，et al. Berberine attenuates septic cardiomyopathy by inhibiting TLR4/NF-kappaB signalling in rats[J]. Pharm Biol，2021，59（1）：121-128.
[8] 刘新强，温妙云，李旭声，等. β1受体阻滞剂通过TLR4/NF-κB信号通路抑制脓毒症心肌炎症反应[J]. 中华危重病急救医学，2019，31（2）：193-197.
[9] WU D，WANG L，HONG D，et al. Interleukin 35 contributes to immunosuppression by regulating inflammatory cytokines and T cell populations in the acute phase of sepsis[J]. Clin Immunol，2022， 235：108915.
[10] LU J，LIU F，YU X，et al. The anti-inflammatory and antiapoptotic effects of nicorandil in antisepsis cardiomyopathy[J]. Cardiovasc Ther，2021，2021：5822920.
[11] LI H，ZHANG S，LI F，et al. NLRX1 attenuates apoptosis and inflammatory responses in myocardial ischemia by inhibiting MAVS-dependent NLRP3 inflammasome activation[J]. Mol Immunol，2016，76：90-97.
[12] HSU W T，GALM B P，SCHRANK G，et al. Effect of renin-angiotensin-aldosterone system inhibitors on short-term mortality after sepsis：a population-based cohort study[J]. Hypertension，2020，75（2）：483-491.
[13] 钱晓东，李晓波，张方芳，等. 卡托普利对病毒感染性心肌炎患者血清肌钙蛋白的影响[J]. 中华医院感染学杂志，2020，30（11）：1708-1712.
[14] KIM J M，HEO H S，CHOI Y J，et al. Inhibition of NF-kappaB-induced inflammatory responses by angiotensin Ⅱ antagonists in aged rat kidney[J]. Exp Gerontol，2011，46（7）：542-548.
[15] CHEN J，LAI J，YANG L，et al. Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1[J]. Br J Pharmacol，2016，173（3）：545-561.
[16] LIU L，WU H，ZANG J，et al. 4-Phenylbutyric acid reveals good beneficial effects on vital organ function via anti-endoplasmic reticulum stress in septic rats[J]. Crit Care Med，2016，44（8）：e689-e701.
[17] 吴禹岑，刘岩. 肾素-血管紧张素系统及核因子-κB在急性胰腺炎中的共同作用[J]. 中华急诊医学杂志，2016，25（1）：116-121.
[18] SHANG X，LIN K，YU R，et al. Resveratrol protects the myocardium in sepsis by activating the phosphatidylinositol 3-kinases （PI3K）/AKT/mammalian target of rapamycin （mTOR） pathway and inhibiting the nuclear factor-kappab（NF-kappaB） signaling pathway[J]. Med Sci Monit，2019，25：9290-9298.

相似文献/References:

[1]高秋文,谢克亮,王卫娜,等.氢气对脓毒症小鼠存活率和肝脏损伤的保护作用[J].天津医科大学学报,2013,19(06):449.
　GAO Qiu-wen,XIE Ke-liang,WANG Wei-na,et al.Protective effects of hydrogen gas on survival rate and liver injury in septic mice[J].Journal of Tianjin Medical University,2013,19(05):449.
[2]高秋文,谢克亮,陈红光,等.Nrf2在富氢液减轻小鼠脓毒症氧化损伤中的作用[J].天津医科大学学报,2014,20(05):354.
　GAO Qiu-wen,XIE Ke-liang,CHEN Hong-guang,et al.Effect of Nrf2 in hydrogen-rich saline to reduce the oxidative damage in septic mice[J].Journal of Tianjin Medical University,2014,20(05):354.
[3]王彦峰,白 洁,李光明,等.血清降钙素原与肾上腺髓质素前体中段肽在婴幼儿细菌性肺炎诊疗中的临床研究[J].天津医科大学学报,2017,23(04):314.
　WANG Yan-feng,BAI Jie,LI Guang-ming,et al.Clinical research of serum procalcitonin and MR-pro-adrenomedullin in the diagnosis and treatment of bacterial pneumonia in infants[J].Journal of Tianjin Medical University,2017,23(05):314.
[4]齐 颖,陈 兵.脓毒性休克限制性液体复苏的临床研究[J].天津医科大学学报,2017,23(04):324.
　QI Ying,CHEN Bing.Clinical study on limited fluid resuscitation in septic shock[J].Journal of Tianjin Medical University,2017,23(05):324.
[5]杨蕊,许华,王兵,等.IL-18在脓毒症及脓毒症休克中预测死亡的作用[J].天津医科大学学报,2018,24(02):142.
　YANG Rui,XU Hua,WANG Bing,et al.Role of IL-18 in predicting mortality of patients with sepsis and septic shock[J].Journal of Tianjin Medical University,2018,24(05):142.
[6]杨宏伟,牛文彦.探讨uKIM-1、IL-6、T细胞亚群在脓毒症急性肾损伤中早期检测的意义[J].天津医科大学学报,2018,24(02):145.
　YANG Hong-wei,NIU Wen-yan.Value of measuring uKIM，IL-6 and T-cell subsets in sepsis patients with acute kidney injury[J].Journal of Tianjin Medical University,2018,24(05):145.
[7]黄 颖,曹 超,王 军,等.TLR4在脓毒症中对调节性T细胞功能活性的影响[J].天津医科大学学报,2018,24(06):492.
　HUANG Ying,CAO Chao,WANG Jun,et al.The effects of TLR4 on regulating the function of Tregs in sepsis[J].Journal of Tianjin Medical University,2018,24(05):492.
[8]吴 枫,李燕华,高玉雷,等.蛋白C活性联合D-二聚体在脓毒症和脓毒性休克患者病情评估中的预测价值研究[J].天津医科大学学报,2019,25(03):229.
　WU Feng,LI Yan-Hua,GAO Yu-Lei,et al.Predictive value of protein C activity combined with D-dimer in the evaluation of sepsis and septic shock[J].Journal of Tianjin Medical University,2019,25(05):229.
[9]郭 菲,王力军,么 颖,等.血浆组蛋白H4与脓毒症患者严重程度及预后关系研究[J].天津医科大学学报,2019,25(05):475.
　GUO Fei,WANG Li-jun,YAO Ying,et al.Prognostic value of plasma histone H4 in septic patients[J].Journal of Tianjin Medical University,2019,25(05):475.
[10]余信,蒋佳维,许华,等.血小板联合D-二聚体对脓毒症预后的评估价值[J].天津医科大学学报,2020,26(02):145.
　YU Xin,JIANG Jia-wei,XU Hua,et al.Prognostic value of platelet combined with D-dimer in sepsis[J].Journal of Tianjin Medical University,2020,26(05):145.

备注/Memo

备注/Memo:

基金项目 国家自然科学基金（81871593）
作者简介 孟祥龙（1988-），男，硕士在读，研究方向：脓毒症；通信作者：柴艳芬，E-mail：chaiyanfen2012@126.com。

常用功能

更新日期/Last Update: 2022-09-20